Condition
Cervical Preparation
Total Trials
5
Recruiting
1
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
75%
3 of 4 completed with results
Key Signals
3 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
P 1 (1)
P 3 (1)
P 4 (1)
Trial Status
Completed4
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06502158Phase 1RecruitingPrimary
Mifepristone vs Misoprostol
NCT07641595Not ApplicableCompleted
Evening Primorose Oil Versus Misoprostol in Cervical Preparation Before Operative Hysteroscopy
NCT03080493Phase 4Completed
Gabapentin for Pain Control After Osmotic Dilator Insertion and Prior to D&E Procedure: a Randomized Controlled Trial
NCT01436279Phase 3CompletedPrimary
Mifepristone Versus Osmotic Dilator Insertion for Cervical Preparation Prior to Surgical Abortion at 15-18 Weeks
NCT00775983Not ApplicableCompletedPrimary
Dilapan Versus Laminaria
Showing all 5 trials